Skip to Content
Merck
All Photos(1)

Documents

SAB1305510

Sigma-Aldrich

MONOCLONAL ANTI-PDGFR antibody produced in mouse

clone 275CT1, crude ascites, buffered aqueous solution

Synonym(s):

Beta platelet-derived growth factor receptor, PDGFR, PDGFR1, PDGFRB, Platelet-derived growth factor receptor beta

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

Quality Level

100

antibody form

crude ascites

antibody product type

primary antibodies

clone

275CT1, monoclonal

form

buffered aqueous solution

mol wt

123968 Da

species reactivity

mouse

technique(s)

western blot: 1:500-1:16000

isotype

IgG1κ

NCBI accession no.

NP_002600.1

UniProt accession no.

P09619

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... PDGFRB(5159)

Related Categories

Physical form

Supplied in PBS with 0.09% (W/V) sodium azide

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Wulfran Cacheux et al.
International journal of cancer, 145(7), 1852-1859 (2019-02-05)
Anal squamous cell carcinoma (ASCC) is a rare tumour, but its incidence is increasing. Standard chemoradiotherapy fails to cure 20% of patients and no targeted therapy is currently approved for recurrent ASCC. The PI3K/Akt/mTOR pathway is frequently altered in this

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service